The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians
about
Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic HyperplasiaAn evidence-based review of NX1207 and its potential in the treatment of benign prostatic hyperplasiaMinimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies.A synopsis of drugs currently in preclinical and early clinical development for the treatment of benign prostatic hyperplasia.New intraprostatic injectables and prostatic urethral lift for male LUTS.Emerging drugs for the treatment of benign prostatic hyperplasia.Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement.
P2860
Q26741226-ECAF3CEB-EC8A-42CA-81B3-285E489C461AQ27028037-67AB88B4-0034-46F0-9B2E-5E380A058DC7Q33739120-8FB59610-0B3D-478A-B192-77E92B034D01Q38485721-6D28260D-47DB-4F4C-8056-6B4EC1D03A41Q38551294-10E70AA0-EC08-4A87-9045-F893826C5997Q47553287-99F91B2D-3775-4D45-B83B-4D121717A9F9Q48145224-744F63DE-BB6C-4B25-95C4-DFA8A5153A84
P2860
The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians
@en
type
label
The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians
@en
prefLabel
The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians
@en
P2860
P356
P1476
The potential for NX-1207 in benign prostatic hyperplasia: an update for clinicians
@en
P2093
Barrett Cowan
Neal Shore
P2860
P304
P356
10.1177/2040622311423128
P577
2011-11-01T00:00:00Z